Johnson & Johnson Drops 5.63% in Four Days Despite Strong Q1 Earnings, Ranks 47th in Trading Volume

Johnson & Johnson (JNJ) experienced a significant decline, dropping 3.70% over the past four days, with a cumulative decrease of 5.63%. The company's trading volume reached 15.49 billion on May 13, 2025, ranking it 47th in the day's trading activity.

Johnson & Johnson recently held its first-quarter 2025 earnings call on April 15, 2025, where the company reported earnings per share (EPS) of $2.77, surpassing analysts' estimates of $2.59. The company's revenue for the quarter was $21.89 billion, reflecting strong financial performance.

In addition to its financial results, Johnson & Johnson held its Annual General Meeting on April 24, 2025, and released its Q1 2025 earnings on April 15, 2025. These events are part of the company's ongoing efforts to maintain transparency and engage with its shareholders.

Johnson & Johnson's financial health is robust, with a net income of $14 billion over the last four quarters, resulting in a net income margin of 15.8%. The company's debt stands at $37 billion, while its market capitalization is $371 billion as of May 12, 2025. This financial stability is a key factor in the company's ability to navigate market fluctuations and maintain investor confidence.